Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
PFE — Pfizer Inc.
NYSE
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

FEB 3, 2026
REVENUE
$17.56B +5.4%
NET MARGIN
-9.4% -30.6 PTS
EPS
-$0.29 -146.8%
FREE CASH FLOW
$4.50B +12.6%

No summary has been written for this call yet.